These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9587132)

  • 21. Seasonal variations in vanillylmandelic acid and homovanillic acid in infants' urine.
    Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
    Jpn J Clin Oncol; 1987 Jun; 17(2):151-5. PubMed ID: 3613139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for neuroblastoma in France: methodological aspects and preliminary observations.
    Chauvin F; Mathieu P; Frappaz D; Lasset C; Favrot MC; Greffe J; Esteve J; Thiesse P; Combaret V; Chauvot P; Boschetti R; David L; Brunat-Mentigny M; Philip T
    Med Pediatr Oncol; 1997 Feb; 28(2):81-91. PubMed ID: 8986143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for neuroblastoma in North America. Preliminary results of a pathology review from the Quebec Project.
    Takeuchi LA; Hachitanda Y; Woods WG; Tuchman M; Lemieux B; Brisson L; Bernstein M; Brossard J; Leclerc JM; Byrne TD
    Cancer; 1995 Dec; 76(11):2363-71. PubMed ID: 8635044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 5-year (1990-1994) neuroblastoma screening feasibility study in France. Methodology and preliminary observations.
    Mathieu P; Frappaz D; Chauvin F; Combaret V; Vercherat M; Brunat-Mentigny M; David L; Esteve J; Favrot M; Fouillat V; Greffe J; Lasset C; Renaud P; Philip T
    Early Hum Dev; 1996 Sep; 46(1-2):177-96. PubMed ID: 9019414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot study of screening for neuroblastoma in the north of England.
    Craft AW; Parker L; Dale G; McGill AC; Seviour JA; Bell S; Cole M; Smith J
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):337-41. PubMed ID: 1456400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mass screening for neuroblastoma in Japan.
    Sawada T; Sugimoto T; Kawakatsu H; Matsumura T; Matsuda Y
    Pediatr Hematol Oncol; 1991; 8(2):93-109. PubMed ID: 1863547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children.
    Bessho F; Hashizume K; Nakajo T; Kamoshita S
    J Pediatr; 1991 Aug; 119(2):237-41. PubMed ID: 1861208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement in prognosis of neuroblastoma through mass population screening.
    Naito H; Sasaki M; Yamashiro K; Takeda T; Takasugi N; Uchino J; Hata Y
    J Pediatr Surg; 1990 Feb; 25(2):245-8. PubMed ID: 2303994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple coloured-paper thin-layer chromatography test as a backup procedure for vanillylmandelic acid and homovanillic acid evaluation in a neuroblastoma screening program.
    Mathieu P; Philip T; Greffe J; Montegue A; Lacroix C
    Clin Chim Acta; 1993 Nov; 220(2):229-32. PubMed ID: 8111967
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuroblastoma screening in the United States: results of the Texas Outreach Program for neuroblastoma screening.
    Ater JL; Gardner KL; Foxhall LE; Therrell BL; Bleyer WA
    Cancer; 1998 Apr; 82(8):1593-602. PubMed ID: 9554539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between homovanillic/vanillylmandelic acid ratios and prognosis in neuroblastoma.
    Nishi M; Miyake H; Takeda T; Hanai J; Fujita K; Ichimiya H; Tanaka T; Hirama T; Ishikawa Y; Kudoh T; Azuma H; Takase A
    Oncol Rep; 1998; 5(3):631-3. PubMed ID: 9538165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for neuroblastoma in the north of England.
    Parker L; Craft AW; Dale G; Bell S; Cole M; McGill AC; Seviour JA; Smith J
    BMJ; 1992 Nov; 305(6864):1260-3. PubMed ID: 1303649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of cut off values for vanillylmandelic acid and homovanillic acid in 24-hr urine accumulation during mass screening for neuroblastoma.
    Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
    Jpn J Clin Oncol; 1987 Sep; 17(3):221-8. PubMed ID: 3669365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. False positive results in a neuroblastoma screening programme.
    Bell S; Parker L; Craft AW; Dale G; McGill AC; Seviour J; Cole M; Smith J
    Med Pediatr Oncol; 1994; 22(3):181-6. PubMed ID: 8272007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can mass screening for neuroblastoma detect patients with low vanillylmandelic acid and high homovanillic acid?
    Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
    Acta Paediatr Jpn; 1989 Dec; 31(6):742-4. PubMed ID: 2516402
    [No Abstract]   [Full Text] [Related]  

  • 36. Screening for neuroblastoma and age-specific incidence.
    Moe PJ
    Acta Paediatr; 1999 Apr; 88(4):362-4. PubMed ID: 10342530
    [No Abstract]   [Full Text] [Related]  

  • 37. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study.
    Hiyama E; Iehara T; Sugimoto T; Fukuzawa M; Hayashi Y; Sasaki F; Sugiyama M; Kondo S; Yoneda A; Yamaoka H; Tajiri T; Akazawa K; Ohtaki M
    Lancet; 2008 Apr; 371(9619):1173-80. PubMed ID: 18395578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Problems of neuroblastoma screening for 6 month olds and results of second screening for 18 month olds.
    Hayashi Y; Ohi R; Yaoita S; Nakamura M; Kikuchi Y; Konno T; Tsuchiya S; Shiraishi H
    J Pediatr Surg; 1995 Mar; 30(3):467-70. PubMed ID: 7760244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for neuroblastoma in the northern region of England. Laboratory aspects.
    Seviour JA; McGill AC; Craft AW; Parker L; Bell S; Cole M; Smith J; Hawkins E; Brown J; Dale GA
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):332-6. PubMed ID: 1456399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of vanillylmandelic acid, vanillactic acid, and homovanillic acid in dried urine on filter-paper discs by high-performance liquid chromatography with coulometric electrochemical detection for neuroblastoma screening.
    Kinoshita Y; Yamada S; Haraguchi K; Takayanagi T; Mori Y; Takahashi T; Haruki E
    Clin Chem; 1988 Nov; 34(11):2228-30. PubMed ID: 3180413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.